S. Leander

2.0k total citations
36 papers, 1.7k citations indexed

About

S. Leander is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, S. Leander has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 6 papers in Social Psychology. Recurrent topics in S. Leander's work include Neuropeptides and Animal Physiology (25 papers), Receptor Mechanisms and Signaling (14 papers) and Neuroendocrine regulation and behavior (6 papers). S. Leander is often cited by papers focused on Neuropeptides and Animal Physiology (25 papers), Receptor Mechanisms and Signaling (14 papers) and Neuroendocrine regulation and behavior (6 papers). S. Leander collaborates with scholars based in Sweden, United States and Switzerland. S. Leander's co-authors include R. Håkanson, F. Sundler, Karl Folkers, J. Hörig, Sune Rosell, S. Thesleff, Håkan Lundh, Kristina Törnqvist, R. H�kanson and Ernst Brodin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

S. Leander

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Leander Sweden 23 1.2k 833 424 252 157 36 1.7k
H. Tamir United States 25 877 0.7× 905 1.1× 348 0.8× 289 1.1× 174 1.1× 45 2.2k
B. Sporrong Sweden 22 492 0.4× 468 0.6× 205 0.5× 222 0.9× 146 0.9× 41 1.4k
K. Uvnäs‐Wallensten Sweden 23 988 0.8× 722 0.9× 314 0.7× 620 2.5× 152 1.0× 49 1.9k
L. O. Uttenthal United Kingdom 29 714 0.6× 587 0.7× 483 1.1× 360 1.4× 189 1.2× 48 1.9k
P Oehme Germany 18 1.0k 0.9× 843 1.0× 562 1.3× 135 0.5× 84 0.5× 150 1.8k
D. H. Coy United States 25 921 0.8× 777 0.9× 132 0.3× 326 1.3× 96 0.6× 57 1.8k
Alain Cadieux Canada 23 1.3k 1.1× 832 1.0× 440 1.0× 246 1.0× 133 0.8× 53 1.7k
K J Chang United States 26 2.1k 1.7× 1.9k 2.2× 566 1.3× 125 0.5× 174 1.1× 35 2.5k
G Burnstock United Kingdom 19 447 0.4× 624 0.7× 432 1.0× 165 0.7× 106 0.7× 40 2.0k
G.M. Makhlouf United States 30 1.2k 1.0× 981 1.2× 494 1.2× 564 2.2× 171 1.1× 54 2.2k

Countries citing papers authored by S. Leander

Since Specialization
Citations

This map shows the geographic impact of S. Leander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Leander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Leander more than expected).

Fields of papers citing papers by S. Leander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Leander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Leander. The network helps show where S. Leander may publish in the future.

Co-authorship network of co-authors of S. Leander

This figure shows the co-authorship network connecting the top 25 collaborators of S. Leander. A scholar is included among the top collaborators of S. Leander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Leander. S. Leander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Håkanson, Rolf, S. Leander, Naoki Asano, Dong-Mei Feng, & Karl Folkers. (1990). Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect. Regulatory Peptides. 31(1). 75–82. 34 indexed citations
2.
Leander, S., et al.. (1990). Systemic and intraocular uptake of spantide, a tachykinin antagonist, following topical application to the rabbit eye. Experimental Eye Research. 50(1). 21–26. 5 indexed citations
3.
Folkers, Karl, et al.. (1990). Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.. Proceedings of the National Academy of Sciences. 87(12). 4833–4835. 55 indexed citations
4.
Freedman, Jacob, T. H�kfelt, C. Post, et al.. (1989). Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone. Experimental Brain Research. 74(2). 279–92. 16 indexed citations
5.
Ljungqvist, Anders, Wolfgang Bender, R. Håkanson, et al.. (1989). Increased potency of antagonists of substance P having asparagine in position 6. Regulatory Peptides. 24(3). 283–291. 11 indexed citations
6.
Barthó, L., Peter Holzer, S. Leander, & F. Lembeck. (1989). Evidence for an involvement of substance P, but not cholecystokinin-like peptides, in hexamethonium-resistant intestinal peristalsis. Neuroscience. 28(1). 211–217. 34 indexed citations
7.
Håkanson, R., et al.. (1988). Blockade of sensory nerve mediated contraction of the rabbit iris sphincter by a series of novel tachykinin antagonists. Regulatory Peptides. 20(2). 99–105. 11 indexed citations
8.
Bynke, Gunnel, R. Håkanson, J. Hörig, & S. Leander. (1983). Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P. European Journal of Pharmacology. 91(4). 469–475. 36 indexed citations
9.
Leander, S., et al.. (1983). Gastrins and cholecystokinins release acetylcholine but not substance P from neurons in the guinea-pig taenia coli. European Journal of Pharmacology. 90(2-3). 245–250. 8 indexed citations
10.
Håkanson, R., F. Sundler, E. Moghimzadeh, & S. Leander. (1983). Peptide-containing nerve fibres in the airways: distribution and functional implications.. PubMed. 131. 115–40. 29 indexed citations
11.
Helm, G., R. Håkanson, S. Leander, et al.. (1982). Neurogenic relaxation mediated by vasoactive intestinal polypeptide (VIP) in the isthmus of the human fallopian tube. Regulatory Peptides. 3(2). 145–153. 22 indexed citations
12.
Fletcher, R., et al.. (1981). MALIGNANT HYPERTHERMIA SYNDROME IN AN ANXIOUS PATIENT. British Journal of Anaesthesia. 53(9). 993–995. 14 indexed citations
13.
Brodin, Ernst, J. Alumets, R. H�kanson, S. Leander, & F. Sundler. (1981). Immunoreactive substance P in the chicken gut: Distribution, development and possible functional significance. Cell and Tissue Research. 216(3). 455–69. 67 indexed citations
14.
Håkanson, R., et al.. (1981). A Substance P Antagonist, [D-Pro 2 , D-Trp 7,9 ]SP, Inhibits Inflammatory Responses in the Rabbit Eye. Science. 214(4524). 1029–1031. 110 indexed citations
15.
Leander, S., R. Håkanson, Sune Rosell, et al.. (1981). A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature. 294(5840). 467–469. 230 indexed citations
16.
Malmfors, G., S. Leander, Ernst Brodin, et al.. (1981). Peptide-containing neurons intrinsic to the gut wall. Cell and Tissue Research. 214(2). 225–38. 52 indexed citations
17.
Leander, S. & S. Thesleff. (1980). On the mode of action of botulinum toxin. Acta Physiologica Scandinavica. 108(2). 195–196. 1 indexed citations
18.
Fohlman, Jan, et al.. (1979). Chemical Modification of Taipoxin and the Consequences for Phospholipase Activity, Pathophysiology, and Inhibition of High‐Affinity Choline Uptake. European Journal of Biochemistry. 94(2). 531–540. 45 indexed citations
19.
Leander, S., Anders Arner, & Börje Johansson. (1977). Effects of 4-aminopyridine on mechanical activity and noradrenaline release in the rat portal vein in vitro. European Journal of Pharmacology. 46(4). 351–361. 48 indexed citations
20.
Lundh, Håkan, S. Leander, & S. Thesleff. (1977). Antagonism of the paralysis produced by botulinum toxin in the rat. Journal of the Neurological Sciences. 32(1). 29–43. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Tamir Breakdown of academic impact, for papers by B. Sporrong Breakdown of academic impact, for papers by K. Uvnäs‐Wallensten Breakdown of academic impact, for papers by L. O. Uttenthal Breakdown of academic impact, for papers by P Oehme Breakdown of academic impact, for papers by D. H. Coy Breakdown of academic impact, for papers by Alain Cadieux Breakdown of academic impact, for papers by K J Chang Breakdown of academic impact, for papers by G Burnstock Breakdown of academic impact, for papers by G.M. Makhlouf
Rankless by CCL
2026